Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Effects of a DPP-4 inhibitor and RAS blockade on clinical outcomes of patients with diabetes and COVID-19
Sang Youl Rhee, Jeongwoo Lee, Hyewon Nam, et al.
medRxiv (Cold Spring Harbor Laboratory) (2020)
Open Access | Times Cited: 31

Showing 1-25 of 31 citing articles:

Diabetes, obesity, metabolism, and SARS-CoV-2 infection: the end of the beginning
Daniel J. Drucker
Cell Metabolism (2021) Vol. 33, Iss. 3, pp. 479-498
Open Access | Times Cited: 241
The Structure of the Membrane Protein of SARS-CoV-2 Resembles the Sugar Transporter SemiSWEET
Sunil Thomas
Pathogens and Immunity (2020) Vol. 5, Iss. 1, pp. 342-342
Open Access | Times Cited: 158
Diabetes, obesity, and insulin resistance in COVID-19: molecular interrelationship and therapeutic implications
Andrey Santos, Daniéla Oliveira Magro, Rosana Evangelista Poderoso, et al.
Diabetology & Metabolic Syndrome (2021) Vol. 13, Iss. 1
Open Access | Times Cited: 121
Forensic and Pharmaceutical Risks in the Organization of Pharmacotherapy of Covid, Post-Covid and Long-Covid Disorders. COVID-19 and Vaccination Practice Standards.
Вікторія Шаповалова
SSP Modern Pharmacy and Medicine (2022) Vol. 2, Iss. 4, pp. 1-24
Open Access | Times Cited: 73
Mortality and other adverse outcomes in patients with type 2 diabetes mellitus admitted for COVID-19 in association with glucose-lowering drugs: a nationwide cohort study
Luis M. Pérez-Belmonte, José D. Torres‐Peña, Maria D. López‐Carmona, et al.
BMC Medicine (2020) Vol. 18, Iss. 1
Open Access | Times Cited: 96
Covid-19 and Diabetes: A Complex Bidirectional Relationship
Hermine Muniangi-Muhitu, Elina Akalestou, Victoria Salem, et al.
Frontiers in Endocrinology (2020) Vol. 11
Open Access | Times Cited: 92
COVID-19 and Diabetes
Awadhesh Kumar Singh, Kamlesh Khunti
Annual Review of Medicine (2021) Vol. 73, Iss. 1, pp. 129-147
Closed Access | Times Cited: 80
Disentangling conflicting evidence on DPP-4 inhibitors and outcomes of COVID-19: narrative review and meta-analysis
Benedetta Maria Bonora, Angelo Avogaro, Gian Paolo Fadini
Journal of Endocrinological Investigation (2021) Vol. 44, Iss. 7, pp. 1379-1386
Open Access | Times Cited: 44
Dipeptidyl peptidase 4 (DPP4) inhibitor and outcome from coronavirus disease 2019 (COVID-19) in diabetic patients: a systematic review, meta-analysis, and meta-regression
Timotius Ivan Hariyanto, Andree Kurniawan
Journal of Diabetes & Metabolic Disorders (2021) Vol. 20, Iss. 1, pp. 543-550
Open Access | Times Cited: 43
DPP-4 inhibition and COVID-19: From initial concerns to recent expectations
André Scheen
Diabetes & Metabolism (2020) Vol. 47, Iss. 2, pp. 101213-101213
Open Access | Times Cited: 43
The Effect of Prior Angiotensin-Converting Enzyme Inhibitor and Angiotensin Receptor Blocker Treatment on Coronavirus Disease 2019 (COVID-19) Susceptibility and Outcome: A Systematic Review and Meta-analysis
Jiuyang Xu, Yaqun Teng, Lianhan Shang, et al.
Clinical Infectious Diseases (2020) Vol. 72, Iss. 11, pp. e901-e913
Open Access | Times Cited: 42
Non-insulin anti-diabetic agents in patients with type 2 diabetes and COVID-19: A Critical Appraisal of Literature
Awadhesh Kumar Singh, Ritu Singh, Banshi Saboo, et al.
Diabetes & Metabolic Syndrome Clinical Research & Reviews (2020) Vol. 15, Iss. 1, pp. 159-167
Open Access | Times Cited: 34
Possible Role of Adenosine in COVID-19 Pathogenesis and Therapeutic Opportunities
Jonathan D. Geiger, Nabab Khan, Madhuvika Murugan, et al.
Frontiers in Pharmacology (2020) Vol. 11
Open Access | Times Cited: 31
A systematic review and meta‐analysis of the use of renin‐angiotensin system drugs and COVID‐19 clinical outcomes: What is the evidence so far?
Amanj Kurdi, Nouf Abutheraa, Lina Akil, et al.
Pharmacology Research & Perspectives (2020) Vol. 8, Iss. 6
Open Access | Times Cited: 23
Impact of diabetes on COVID-19-related in-hospital mortality: a retrospective study from Northern Italy
Stefano Ciardullo, Francesca Zerbini, Silvia Perra, et al.
Research Square (Research Square) (2020)
Open Access | Times Cited: 13
Renin–angiotensin–aldosterone system blockers and region-specific variations in COVID-19 outcomes: findings from a systematic review and meta-analysis
Upinder Kaur, Sankha Shubhra Chakrabarti, Tejas Patel
Therapeutic Advances in Drug Safety (2021) Vol. 12
Open Access | Times Cited: 12
Mortality and Severity in COVID-19 Patients on ACEIs & ARBs - A Meta-Regression Analysis
Romil Singh, Sawai Singh Rathore, Hira Khan, et al.
medRxiv (Cold Spring Harbor Laboratory) (2021)
Open Access | Times Cited: 9
Dipeptidyl-peptidase-4 inhibitors in type 2 diabetes and COVID-19: From a potential repurposed agent to a useful treatment option
Awadhesh Kumar Singh, Ritu Singh
Journal of Diabetology (2020) Vol. 11, Iss. 3, pp. 131-131
Open Access | Times Cited: 8
The Structure of the Membrane Protein of SARS-CoV-2 Resembles the Sugar Transporter semiSWEET
Sunil Thomas
(2020)
Open Access | Times Cited: 8
Association Between ACEIs or ARBs Use and Clinical Outcomes in COVID-19 Patients: A Systematic Review and Meta-analysis
Carlos Diaz‐Arocutipa, Jose Saucedo‐Chinchay, Adrían V. Hernández
medRxiv (Cold Spring Harbor Laboratory) (2020)
Open Access | Times Cited: 6
Association between prior cardiometabolic therapy and in-hospital mortality in very old patients with type 2 diabetes mellitus hospitalized due to COVID-19. A nationwide observational study in Spain
Juan Carlos Ramos Ramos, Luis M. Pérez‐Belmonte, Francisco Javier Carrasco-Sánchez, et al.
Research Square (Research Square) (2020)
Closed Access | Times Cited: 3
Potential use of plant-based therapeutics for the management of SARS-COV2 infection in Diabetes mellitus- A review
Neha Deora, Krishnan Venkatraman
Journal of Herbal Medicine (2024) Vol. 47, pp. 100923-100923
Closed Access
The Association Between Hypoglycemic Agents and Clinical Outcomes of COVID-19 in Patients with Diabetes: A Systematic Review and Meta-Analysis
Tiantian Han, Shaodi Ma, Chenyu Sun, et al.
medRxiv (Cold Spring Harbor Laboratory) (2021)
Open Access | Times Cited: 3
RAAS Blockers and Region-Specific Variations in COVID-19 Outcomes: Findings from a Systematic Review and Meta-Analysis
Upinder Kaur, Sankha Shubhra Chakrabarti, Tejas Patel
SSRN Electronic Journal (2020)
Open Access | Times Cited: 2
The Structure of the Membrane Protein of SARS-CoV-2 Resembles the Sugar Transporter semiSWEET
Sunil Thomas
(2020)
Open Access | Times Cited: 2
Page 1 - Next Page

Scroll to top